GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Stereotaxis, Inc. (STXS) [hlAlert]

Rating:
Buy STXS
down 96.43 %

Stereotaxis, Inc. (STXS) rated Buy with price target $7 by Soleil

Posted on: Tuesday,  Oct 6, 2009  8:25 AM ET by Soleil

Soleil rated Buy Stereotaxis, Inc. (NASDAQ: STXS) on 10/06/2009, when the stock price was $44.00. Since
then, Stereotaxis, Inc. has lost 96.43% as of 01/21/2016's recent price of $1.57.
If you would have followed this Soleil's recommendation on STXS, you would have lost 96.43% of your investment in 2298 days.

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites.

Soleil focuses on institutional research without ties to proprietary trading. By aggregating unbiased, actionable research, we allow our institutional clients to access a variety of perspectives and investment opinions from one trusted source. Our experienced sales professionals and research production team evaluate and filter dozens of independent research analysts to create a select group of research partners that best serve our clients. Each of our analysts has considerable industry experience, significant institutional relationships, a deep understanding of a particular sector, and the ability to deliver proprietary data and insights. Through expanded coverage of conventional and under-followed companies, they provide multiple perspectives and divergent viewpoints across a variety of industry sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/6/2009 8:25 AM Buy
None
44.00 70.00
as of 12/31/2009
1 Week down  -14.56 %
1 Month down  -7.23 %
3 Months down  -21.36 %
1 YTD down  -21.36 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy